Articles from Biotech Business (May 1, 2006)

Title	Author	Type	Words
DATA SHOWS 2ME2 POTENTIAL AS ANTI-RHEUMATOID DRUG.			536
ORPHAN THERAPEUTICS COMPLETES ENROLLMENT FOR TERLIPRESSIN.			702
SPHERIX MOVES TOWARD FINAL DIABETES TRIALS.			243
TARGET DISCOVERY/VIRGINIA PROSTATE DEVELOP CLINICAL ASSAYS.			628
TENASCIN-C HELPS DIRECT CLOT-INDUCED NEOVASCULARIZION.			815